Peter Lehmann reviews the contribution of antipsychotics to suicide and depression in schizophrenia in the current International Journal of Psychotherapy. Publications about the intrinsic effects of antipsychotics on suicidality – which are “currently taboo,” he says – might reduce suicides in ‘schizophrenics.’ He suggests that a suicide register (akin to the mortality registers used in the medical field to identify connections between reduced life-expectancy and the outcomes of medical treatments) would meaningfully identify and lower the rate of suicide in people with emotional problems.
International Journal of Psychotherapy: 2012, Vol. 16, No 1., pp. 30-49
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.